IDH3A and myelodysplastic syndrome: In AML and myelodysplastic syndrome (MDS), TET2 mutations are mostly mutually exclusive with thosein isocitrate dehydrogenase (IDH1/2),31 which catalyzes decarboxylation of isocitrateto give 2OG.